The Boston Sickle Cell Center is structured into five (5) main components: (1) Administration, (2) Research, (3) Testing, (4) Education and Counseling, and (5) Central Data Bank and Resource File. Through the coordinative efforts of these components the BSCC proposes to reach its specific aims as follows: 1. to sponsor and support research in the field of hemoglobinopathies conducted through our Center in five (5) major institutions in Boston: Boston University School of Medicine, Tufts-New England Medical Center, Children's Hospital Medical Center, Beth Israel Hospital and St. Elizabeth's Hospital; 2. the Center will continue to test the population """"""""at risk"""""""" for hemoglobin S gene and/or G6PD in the Boston area and will expand services to other communities where there is a population """"""""at risk""""""""; 3. the Center will begin to test for beta-thalassemia trait; 4. it will provide education and non-directive counseling to individuals identified with variant hemoglobin traits and G6PD deficiency, and counsel, support and offer direct patient services to individuals with sickle cell disease and their families; 5. it will also increase the level of awareness of knowledge about sickle cell trait and sickle cell disease within the general public through educational programs; and 6. finally it will develop and use evaluative tools to assess the effectiveness of methods used in carrying out its mission.
Showing the most recent 10 out of 39 publications
